Observational Study on GEP-and Pulm-NET Treated at FPG
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
About this trial
Observational ambispective monocentric study on the clinical, laboratory, pathological and molecular characteristics of patients suffering from gastroenteropancreatic tract and pulmonary neuroendocrine tumors and their prognostic and predictive value.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
histological diagnosis of gastroenteropancreatic or pulmonary NET
age ≥ 18 years;
radiological evidence of resectable/locally advanced/metastatic disease;
signing of informed consent;
Disqualifiers
absence of clinical data that allow adequate definition of survival (primary endpoint of the study);
absence of histological diagnosis;
failure to sign the informed consent.
Trial population
Patients ≥ 18 years affected by gastroenteropancreatic or pulmonary NET.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
650 Participants
are grouped into 2 trial groupsGroup A: retrospective cohort
Group B: prospective cohort
Trial outcomes
Primary outcomes
1
Overall Survival
The length of time from the date of diagnosis to death.
Time frame
from randomization to end of study or death event (estimed: up to 36 months).Secondary outcomes
1
Progression Free Survival
The length of time from the date of diagnosis to disease progression.
Time frame
from randomization to progression or death event or end of the study (estimed: up to 36 months).Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov